PROPHASE LABS, INC.

Profile

Company Names

PROPHASE LABS, INC.
QUIGLEY CORP

Addresses

626 RXR PLAZA, 6TH FLOOR, UNIONDALE, NY 11556

621 N. SHADY RETREAT ROAD, DOYLESTOWN, PA 18901

KELLS BUILDING, 621 N. SHADY RETREAT ROAD, DOYLESTOWN, PA 18901

Phone Numbers

215-345-0919
2153450919

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

NEVADA

Total Amount Raised:

$8,423,200.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2025-07-22 
$3,000,000.00 
$6,000,000.00 
$3,000,000.00 
Debt 
3
2025-06-22 
$1,000,000.00 
$1,000,000.00 
$0.00 
Debt 
2
2015-12-11 
$1,500,000.00 
$3,000,000.00 
$1,500,000.00 
Debt 
1
2010-03-22 
$2,923,200.00 
$2,923,200.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CAROLINA 
 
ABENANTE 
DIRECTOR
NYIAX, INC.   |  PROPHASE LABS, INC.
JASON 
 
BARR 
DIRECTOR
IMPROVEIT! 360, LLC   |  BARAK STRUCTURED TRADE FINANCE SEGREGATED PORTFOLIO OF BARAK FUND SPC LTD.   |  PROPHASE LABS, INC.   |  UPDOX LLC
MARK 
 
BURNETT 
DIRECTOR
QUIGLEY CORP   |  HUDSON PACIFIC PROPERTIES, INC.   |  HUDSON PACIFIC PROPERTIES, L.P.   |  PROPHASE LABS, INC.   |  GUARDIAN METAL RESOURCES PLC
ROBERT 
V. 
CUDDIHY, JR. 
EXECUTIVE OFFICER
QUIGLEY CORP   |  PROPHASE LABS, INC.
JOHN 
 
DESHAZO 
DIRECTOR
QUIGLEY CORP
MARK 
 
FRANK 
DIRECTOR
QUIGLEY CORP   |  SONDERMIND LLC
LOUIS 
 
GECKEL 
DIRECTOR
PROPHASE LABS, INC.
LOUIS 
 
GLECKEL 
DIRECTOR
QUIGLEY CORP   |  PROPHASE LABS, INC.
WARREN 
 
HIRSCH 
DIRECTOR
PROPHASE LABS, INC.
TED 
 
KARKUS 
EXECUTIVE OFFICER, DIRECTOR
QUIGLEY CORP   |  PROPHASE LABS, INC.
MARK 
 
LEVENTHAL 
DIRECTOR
HUDSON HOLDING CORP   |  QUIGLEY CORP   |  PROPHASE LABS, INC.   |  NOBLESTONE CAPITAL, LLC   |  NOBLESTONE REAL ESTATE OPPORTUNITIES FUND, LLC   |  26700 LAHSER, LLC   |  NOBLESTONE OX FUND, LLC   |  NOBLESTONE OZ FUND, LLC   |  NOBLESTONE OZ FUND II, LLC   |  NOBLESTONE EXTENDED STAY, LLC   |  HOLDEN CIRCLE LLC   |  NOBLESTONE PRINCETON LLC   |  HOLDEN TRIANGLE LLC   |  PEACHSTONE ROCKFORD, LLC   |  NOBLESTONE PUTNAM LLC   |  NOBLESTONE AMBERLUND LLC   |  NOBLESTONE CREDIT SELECT LLC   |  NOBLESTONE CREDIT SELECT II LLC
JAMES 
 
MCCUBBIN 
DIRECTOR
QUIGLEY CORP   |  PROPHASE LABS, INC.   |  TAVAS 2 HOLDINGS LTD   |  AMERICAN MINERAL TECHNOLOGIES CORP   |  PATHIFY HOLDINGS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-08-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-07-22 
2025-07-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2025-06-22 
2015-12-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2015-12-11 
2010-03-26
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Equity 
2010-03-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NONE
NONE